CYCLOPHARM LIMITED — Director's Dealing 2012

Nov 5, 2012

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity CYCLOPHARM LIMITED ABN 74 116 931 250

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

We (the entity) give ASX the followingthe director for the purposes of section	information under listing rule 3.19A.2 and as agent for205G of the Corporations Act.
Name of Director	James McBrayer
Date of last notice	2/12/2008

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Direct
Nature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to the relevantinterest.	N/A
Date of change	3/06/20103/06/20124/06/201231/10/2012
No. of securities held prior to change	1,559,090
Class	Ordinary Shares
Number acquired	1,341,476
Number disposed	1,527,272
Value/ConsiderationNote: If consideration is non‐cash, provide details and estimatedvaluation	Not applicable
No. of securities held after change	1,373,294

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Nature of change	3/06/2010 : 700,000 Long Term Incentive
Example: on‐market trade, off‐market trade, exercise of options,issue of securities under dividend reinvestment plan, participation inbuy‐back	Plan (LTIP) Shares exercisable at $0.25have lapsed
	3/06/2012:700,000LTIPShares
	exercisable at $0.35 have lapsed
	4/06/2012 : 127,272 reduction in shares
	arising from share consolidation
	31/10/2012 : 894,317 LTIP Shares acquired
	for $0.50 each under a limited recourse
	loan facility provided by the Company for
	2 years
	31/10/2012 : 447,159 LTIP Shares acquired
	for $0.35 each under a limited recourse
	loan facility provided by the Company for
	2 years

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Note: In the case of a cobe disclosed in this part.	mpany, interests which come within paragraph (ii) of the definition of “noti	mpany, interests which come within paragraph (ii) of the definition of “noti	fiable interest of a	director” should	director” should
Detail of contra
	ct	Nil
Nature of intereName of registe(if issued securi	st	Nil
	red holderi	Nil
	tes)
Date of changeNo. and class ointerest relatedNote: Details are onrelation to which the iInterest acquireInterest disposeValue/ConsiderNote: If considerationand an estimated valuInterest after ch		Nil
	f securities to whichprior to change	Nil
	ly required for a contract innterest has changed
	d	Nil
	d	Nil
	tion	Nil
	is non‐cash, provide detailsation
		Nil
	ange
Part 3 –+Close
	d period
S ht f	dfid t

Part 3 –[+] Closed period

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Were the interests in the securities or contracts detailedabove traded during a+closed period where prior writtenclearance was required?	Nil
If so, was prior written clearance provided to allow the tradeto proceed during this period?	Nil
If prior written clearance was provided, on what date was thisprovided?	Nil

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3